Du Jing, Wang Yun, Hunter Richard, Wei Yanling, Blumenthal Rayah, Falke Cynthia, Khairova Rushaniya, Zhou Rulun, Yuan Peixiong, Machado-Vieira Rodrigo, McEwen Bruce S, Manji Husseini K
Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3543-8. doi: 10.1073/pnas.0812671106. Epub 2009 Feb 6.
Glucocorticoids play an important biphasic role in modulating neural plasticity; low doses enhance neural plasticity and spatial memory behavior, whereas chronic, higher doses produce inhibition. We found that 3 independent measures of mitochondrial function-mitochondrial oxidation, membrane potential, and mitochondrial calcium holding capacity-were regulated by long-term corticosterone (CORT) treatment in an inverted "U"-shape. This regulation of mitochondrial function by CORT correlated with neuroprotection; that is, treatment with low doses of CORT had a neuroprotective effect, whereas treatment with high doses of CORT enhanced kainic acid (KA)-induced toxicity of cortical neurons. We then undertook experiments to elucidate the mechanisms underlying these biphasic effects and found that glucocorticoid receptors (GRs) formed a complex with the anti-apoptotic protein Bcl-2 in response to CORT treatment and translocated with Bcl-2 into mitochondria after acute treatment with low or high doses of CORT in primary cortical neurons. However, after 3 days of treatment, high, but not low, doses of CORT resulted in decreased GR and Bcl-2 levels in mitochondria. As with the in vitro studies, Bcl-2 levels in the mitochondria of the prefrontal cortex were significantly decreased, along with GR levels, after long-term treatment with high-dose CORT in vivo. These findings have the potential to contribute to a more complete understanding of the mechanisms by which glucocorticoids and chronic stress regulate cellular plasticity and resilience and to inform the future development of improved therapeutics.
糖皮质激素在调节神经可塑性方面发挥着重要的双相作用;低剂量可增强神经可塑性和空间记忆行为,而长期高剂量则会产生抑制作用。我们发现,线粒体功能的3项独立指标——线粒体氧化、膜电位和线粒体钙容纳能力——受到长期皮质酮(CORT)治疗的“倒U形”调节。CORT对线粒体功能的这种调节与神经保护作用相关;也就是说,低剂量CORT治疗具有神经保护作用,而高剂量CORT治疗则会增强 kainic 酸(KA)诱导的皮质神经元毒性。然后我们进行了实验以阐明这些双相效应的潜在机制,发现糖皮质激素受体(GRs)在CORT治疗后与抗凋亡蛋白Bcl-2形成复合物,并在原代皮质神经元中用低剂量或高剂量CORT急性处理后与Bcl-2一起转运到线粒体中。然而,在治疗3天后,高剂量而非低剂量的CORT导致线粒体中GR和Bcl-2水平降低。与体外研究一样,在体内用高剂量CORT长期治疗后,前额叶皮质线粒体中的Bcl-2水平与GR水平一起显著降低。这些发现有可能有助于更全面地理解糖皮质激素和慢性应激调节细胞可塑性和恢复力的机制,并为未来改进治疗方法的开发提供信息。